Modern algorithm foa the diagnosis of ulcerative colitis in children according to the latest recommendations of the european crohn’s and colitis organization and european society of paediatric gastroenterology, hepatology and nutrition

Authors

  • O. M. Okhotnikova Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine, Ukraine
  • T. M. Tkacheva Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine, Ukraine
  • A. A. Romanchuk National Children's Specialized Hospital «OKHMATDYT», Kyiv, Ukraine, Ukraine
  • O. M. Grishchenko National Children's Specialized Hospital «OKHMATDYT», Kyiv, Ukraine, Ukraine
  • D. S. Voronyak National Children's Specialized Hospital «OKHMATDYT», Kyiv, Ukraine, Ukraine

Keywords:

inflammatory bowel diseases, clinical recommendations, patient management scheme, PIBD-classes, pediatric ulcerative colitis activity index, children

Abstract

According to the staff of the Department of Pediatrics No. 1 of Shupyk National Medical Academy of Postgraduate Education (NMAPO) over the past 20 years, there has been an increase in the number of hospitalizations of children with inflammatory bowel diseases (IBD). However, in Ukraine there is no single center for monitoring children with IBD, so the collection of statistical data is a rather difficult problem. This was facilitated by the lack of a unified approach to diagnosis. The article provides updated recommendations of the ECCO and ESPGHAN (2018) on the classification of IBD in children, their diagnosis algorithm using the criteria of PIBD classes. Statistical data on registration of IBD in children at the pediatric department of National Children's Specialized Hospital «OKHMATDYT» are provided. The given clinical case is an example of applying the criteria for differential diagnosis of various forms of IBD in children, assessing severity and provides a management scheme for patients with this pathology.
Conclusions: Updated recommendations of the ECCO and ESPGHAN facilitate the differential diagnosis of various types of IBD, provide a clear monitoring scheme for children with this pathology, improve treatment outcomes and the quality of life of small patients.

References

Ashorn S, Honkanen T, Kolho KL et al. (2009). Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis.15: 199—205. https://doi.org/10.1002/ibd.20535; PMid:18618670 PMCid:PMC2627785

Ashton JJ, Versteegh HP, Batra A et al. (2016). Colectomy in pediatric ulcerative colitis: a single center experience of indications, outcomes, and complications. J Pediatr Surg.51: 277—81. https://doi.org/10.1016/j.jpedsurg.2015.10.077; PMid:26653944

Benchimol EI, Fortinsky KJ, Gozdyra P et al. (2011). Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis.17: 423—39. https://doi.org/10.1002/ibd.21349; PMid:20564651

Benchimol EI, Guttmann A, To T et al. (2011). Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994—2007). Inflamm Bowel Dis.17: 2153—61. https://doi.org/10.1002/ibd.21591; PMid:21910177

Birimberg-Schwartz L, Wilson DC, Kolho KL et al. (2016). pANCA and ASCA in children with IBD-unclassified, Crohn's colitis, and ulcerative colitis — a longitudinal report from the IBD Porto Group of ESPGHAN. Inflamm Bowel Dis.22: 1908—14. https://doi.org/10.1097/MIB.0000000000000784; PMid:27135480

Birimberg-Schwartz L, Zucker DM, Akriv A et al. (2017). Development and validation of diagnostic criteria for IBD subtypes with an emphasis on IBD-Unclassified in children: a multicenter study from the Pediatric IBD Porto group of ESPGHAN. J Crohns Colitis.11: 1078—84. https://doi.org/10.1093/ecco-jcc/jjx053; PMid:28430891

Borkowska A, Liberek A, Luczak G et al. (2015). Fecal lactoferrin, a marker of intestinal inflammation in children with inflammatory bowel disease. Acta Biochim Pol. 62: 541—5. https://doi.org/10.18388/abp.2015_982; PMid:26339799

Canani RB, Terrin G, Rapacciuolo L et al. (2008). Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Dig Liver Dis.40: 547—53. https://doi.org/10.1016/j.dld.2008.01.017; PMid:18358796

Dan Turner, Frank M. Ruemmele, Esther Orlanski-Meyer et al. (2018). Management of paediatric ulcerative colitis, part 1: ambulatory care an evidence-based guideline from ECCO and ESPGHAN. JPGN.67;2: 260. https://doi.org/10.1097/MPG.0000000000002035

De Ridder L, Turner D, Wilson DC et al. (2014). Malignancy and mortality in pediatric patients with inflammatory bowel disease: a multinational study from the porto pediatric IBD group. Inflamm Bowel Dis.20: 291—300. https://doi.org/10.1097/01.MIB.0000439066.69340.3c; PMid:24374875

Dinesen LC, Walsh AJ, Protic MN et al. (2010). The pattern and outcome of acute severe colitis. J Crohns Colitis.4: 431—7. https://doi.org/10.1016/j.crohns.2010.02.001; PMid:21122540

Fagerberg UL, Loof L, Lindholm J et al. (2007). Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J PediatrGastroenterol Nutr.45: 414—20. https://doi.org/10.1097/MPG.0b013e31810e75a9; PMid:18030206

Fleshner PR, Vasiliauskas EA, Kam LY et al. (2001). High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut.49: 671—7. https://doi.org/10.1136/gut.49.5.671; PMid:11600470 PMCid:PMC1728523

Gower-Rousseau C, Dauchet L, Vernier-Massouille G et al. (2009). The natural history of pediatric ulcerative colitis: a population-based cohort study. Am J Gastroenterol.104: 2080—8. https://doi.org/10.1038/ajg.2009.177; PMid:19436273

Jakobsen C, Bartek J, Wewer V et al. (2011). Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease — a population-based study. Aliment Pharmacol Ther.34: 1217—24. https://doi.org/10.1111/j.1365-2036.2011.04857.x; PMid:21981762

Kelley-Quon LI, Jen HC, Ziring DA et al. (2012). Predictors of proctocolectomy in children with ulcerative colitis. J Pediatr Gastroenterol Nutr.55: 534—40. https://doi.org/10.1097/MPG.0b013e3182619d26; PMid:22684351 PMCid:PMC4378533

Komraus M, Wos H, Wiecek S et al. (2012). Usefulness of faecal calprotectin measurement in children with various types of inflammatory bowel disease. Mediators Inflamm.2012: 608249. https://doi.org/10.1155/2012/608249; PMid:22665952 PMCid:PMC3361316

Langholz E, Munkholm P, Krasilnikoff PA et al. (1997). Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol.32: 139—47. https://doi.org/10.3109/00365529709000184; PMid:9051874

Levine A, Koletzko S, Turner D et al. (2014). The ESPGHAN Revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr.58: 795—806.

Lobaton T, Bessissow T, De Hertogh G et al. (2015). The Modified Mayo Endoscopic Score (MMES): a new index for the assessment of extension and severity of endoscopic activity in ulcerative colitis patients. J Crohns Colitis.9: 846—52. https://doi.org/10.1093/ecco-jcc/jjv111; PMid:26116558

Mack DR, Langton C, Markowitz J et al. (2007). Laboratory values for children with newly diagnosed inflammatory bowel disease. Pediatrics.119: 1113—9. https://doi.org/10.1542/peds.2006-1865; PMid:17545378

Miele E, Pascarella F, Quaglietta L et al. (2007). Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis. Aliment Pharmacol Ther.25: 933—9. https://doi.org/10.1111/j.1365-2036.2007.03291.x; PMid:17402997

Moore JC, Thompson K, Lafleur B et al. (2011). Clinical variables as prognostic tools in pediatric-onset ulcerative colitis: a retrospective cohort study. Inflamm Bowel Dis.17: 15—21. https://doi.org/10.1002/ibd.21393; PMid:20629099

Olen O, Askling J, Sachs MC et al. (2017). Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964—2014.BMJ.358: 3951. https://doi.org/10.1136/bmj.j3951; PMid:28931512 PMCid:PMC5605779

Roszak D, Galecka M, Cichy W et al. (2015). Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseases. Adv Med Sci.60: 246—52. https://doi.org/10.1016/j.advms.2015.04.003; PMid:25989184

Schoepfer AM, Beglinger C, Straumann A et al. (2009). Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflamm Bowel Dis.15: 1851—8. https://doi.org/10.1002/ibd.20986; PMid:19462421

Sidoroff M, Karikoski R, Raivio T et al. (2010). High-sensitivity C-reactive protein in paediatric inflammatory bowel disease. World J Gastroenterol.16: 2901—6. https://doi.org/10.3748/wjg.v16.i23.2901; PMid:20556836 PMCid:PMC2887586

Tibble JA, Sigthorsson G, Bridger S. et al. (2000). Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology.119: 15—22. https://doi.org/10.1053/gast.2000.8523; PMid:10889150

Travis SP, Schnell D, Krzeski P et al. (2012). Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).Gut.61: 535—42. https://doi.org/10.1136/gutjnl-2011-300486; PMid:21997563 PMCid:PMC3292713

Travis SP, Schnell D, Krzeski P et al. (2013). Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology.145: 987—95. https://doi.org/10.1053/j.gastro.2013.07.024; PMid:23891974

Turner D, Mack DR, Hyams J et al. (2011). C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) or both? A systematic evaluation in pediatric ulcerative colitis. J Crohns Colitis.5: 423—9. https://doi.org/10.1016/j.crohns.2011.05.003; PMid:21939916

Turner D, Otley AR, Mack D et al. (2007). Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology.133: 423—32. https://doi.org/10.1053/j.gastro.2007.05.029; PMid:17681163

Turner D, Walsh CM, Benchimol EI et al. (2008). Severe paediatric ulcerative colitis: incidence, outcomes and optimal timing for secondline therapy. Gut.57: 331—8. https://doi.org/10.1136/gut.2007.136481; PMid:17981888

Van Limbergen J, Russell RK, Drummond HE et al. (2008). Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology.135: 1114—22. https://doi.org/10.1053/j.gastro.2008.06.081; PMid:18725221

Weinstein TA, Levine M, Pettei MJ et al. (2003). Age and family history at presentation of pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 37: 609—13. https://doi.org/10.1097/00005176-200311000-00020; PMid:14581806

Zholudev A, Zurakowski D, Young W et al. (2004). Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Am J Gastroenterol.99: 2235—41. https://doi.org/10.1111/j.1572-0241.2004.40369.x; PMid:15555007

Downloads

Issue

No. 7(103) (2019): Modern pediatrics. Ukraine

Section

Reviews

License

The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a  Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).

Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.

Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.

The use of published materials for commercial purposes is strongly prohibited.